<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: The objective of this study was to analyse the incidence and the main characteristics of <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A retrospective review of a well-documented population of 376 Tunisian patients with <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease was performed </plain></SENT>
<SENT sid="2" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients fulfilled three or more criteria defined by the International Study Group for <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's Disease </plain></SENT>
<SENT sid="3" pm="."><plain>The diagnosis of <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> was based on the clinical examination, visual field, visual evoked potentials and <z:chebi fb="46" ids="15035">retinal</z:chebi> angiography </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Eighteen patients (4.7 %) presented an optic nerve involvement </plain></SENT>
<SENT sid="5" pm="."><plain>The mean age at presentation of these patients (10 men and nine women) was 39.11+/-12.9 years (range 17 to 73) </plain></SENT>
<SENT sid="6" pm="."><plain>The mean vision at presentation was 4.2/10+/-2.9, the vision was less than 1/10 in 34.5 % of eyes </plain></SENT>
<SENT sid="7" pm="."><plain>The <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> was anterior in 89 % cases (26 eyes, 90 %), posterior in one case (2 eyes, 7 %); one patient (1 eye, 3 %) presented an <z:hpo ids='HP_0000648'>optic atrophy</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>The <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> was associated with other ocular lesions in 13 cases (72.2 %) </plain></SENT>
<SENT sid="9" pm="."><plain>It was an <z:e sem="disease" ids="C0270933" disease_type="Disease or Syndrome" abbrv="">inflammatory neuropathy</z:e> in four cases (22.3 %) and a stasis <z:hpo ids='HP_0001085'>papilledema</z:hpo> complicating a benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> in five cases (27.8 %) </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="0" ids="50858">Corticosteroids</z:chebi> were administrated in 17 cases (94.4 %), <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> in six cases (33.3 %) and <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy in one patient (5.6 %) </plain></SENT>
<SENT sid="11" pm="."><plain>After a mean duration of 79 months (range: three months to 12 years), a third of the patients (8 eyes, 27.5 %) have a <z:hpo ids='HP_0000572'>visual loss</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0001138'>Optic neuropathy</z:hpo> is a rare ocular involvement in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="13" pm="."><plain>It can be related to an <z:e sem="disease" ids="C0270933" disease_type="Disease or Syndrome" abbrv="">inflammatory neuropathy</z:e>, a stasis <z:hpo ids='HP_0001085'>papilledema</z:hpo> complicating a benign intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> or an <z:e sem="disease" ids="C0238309" disease_type="Disease or Syndrome" abbrv="">ischemic neuropathy</z:e> </plain></SENT>
<SENT sid="14" pm="."><plain>The association of <z:hpo ids='HP_0001138'>optic neuropathy</z:hpo> with other ocular lesions could be responsible for a diagnostic delay </plain></SENT>
<SENT sid="15" pm="."><plain>Its treatment relies on systemic <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and immunosuppressive drugs </plain></SENT>
<SENT sid="16" pm="."><plain>The prognosis remained poor, with a third of the patients having lost their sight </plain></SENT>
</text></document>